Xembify, a 20% concentration SCIg product supplied by Grifols Australia, will be available for supply under the national blood arrangements from January 2024.
The National Blood Authority (NBA) has agreed arrangements with Grifols Australia Pty Ltd for the addition of a Gamunex 10% 40g/400mL vial size under the nation
